US Broker Ratings

Teva Pharmaceutical (TEVA) Stock Analysis: A 21% Upside Potential Amidst a Challenging Market

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global pharmaceutical arena, presents an intriguing opportunity for investors seeking exposure in the healthcare sector. Despite its current price of..

Encompass Health Corporation (EHC) Stock Analysis: A Solid Healthcare Play with 12% Potential Upside

Encompass Health Corporation (NYSE: EHC) stands out within the healthcare sector as a robust player in the medical care facilities industry. With a market capitalization of $12.41 billion, this Birmingham,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Powerhouse with 10.5% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors as it continues to make waves in the healthcare sector, specifically within the biotechnology industry. The company, based in..

Bruker Corporation (BRKR)

⚠️ No article content returned.

..

DaVita Inc. (DVA) Stock Analysis: Strong Revenue Growth and a 17% Upside Potential

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within medical care facilities, is making waves with its financial performance and promising analyst projections. With a market..

The Cooper Companies, Inc. (COO) Stock Analysis: Harnessing an 18% Upside in the Healthcare Sector

Investors with an eye on the healthcare sector would do well to consider The Cooper Companies, Inc. (NYSE: COO), a stalwart in the Medical Instruments & Supplies industry. With a..

Illumina, Inc. (ILMN) Stock Analysis: Exploring Its Growth Potential and Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. Known for its pioneering sequencing and array-based solutions for genetic and..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A Promising Biotech with Nearly 24% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company headquartered in London, is capturing investor interest with its innovative approach to drug development and a promising upside potential of nearly..

Centene Corporation (CNC) Investor Outlook: Navigating a Healthcare Giant Amidst Mixed Analyst Ratings

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $19.01 billion, the company continues to..

Amgen Inc. (AMGN) Stock Analysis: Robust Revenue Growth and Attractive Dividend Yield Captivate Investors

Amgen Inc. (Nasdaq: AMGN), a stalwart in the healthcare sector and a leading player in the drug manufacturing industry, continues to capture investor interest with its robust financial performance and..

Fresenius Medical Care AG (FMS) Investor Outlook: Exploring a Potential 11.55% Upside in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS) stands as a global leader in the healthcare sector, specializing in providing essential dialysis and related services for individuals with renal diseases. With a..

UnitedHealth Group (UNH) Stock Analysis: Navigating a Healthcare Giant with a $326B Market Cap

UnitedHealth Group Incorporated (NYSE: UNH) stands as a formidable titan in the healthcare sector, commanding a market capitalization of $326.22 billion. As the largest healthcare company in the United States..

Insulet Corporation (PODD) Stock Analysis: Unpacking the 17% Upside Amid Robust Revenue Growth

Insulet Corporation (NASDAQ: PODD), a pioneering entity in the healthcare sector, specializes in medical devices, specifically insulin delivery systems. With a market capitalization of $21.76 billion, Insulet stands as a..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Growth Potential Amidst a $8.22 Billion Market Cap

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, has carved a niche in the medical devices industry. Headquartered in Hercules, California, Bio-Rad operates globally, offering life..

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings Amidst Revenue Growth and Strategic Positioning

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a pivotal player in the healthcare sector, specifically within the drug manufacturing industry that caters to both specialty and generic needs. Headquartered..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 15% Potential Upside with Strategic Segment Innovations

Solventum Corporation (SOLV), a significant player in the healthcare sector, is drawing investor attention with its diverse portfolio and a promising potential upside of 15.02% as indicated by recent analyst..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.25% Potential Upside in the Healthcare Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, continues to draw investor attention with its robust portfolio and a potential upside of 9.25%. Headquartered in Melville, New..

Natera, Inc. (NTRA) Stock Analysis: Unveiling Growth Potential Amidst Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA) is capturing investor attention in the healthcare sector with a market capitalization of $22.98 billion. Specializing in diagnostics and research, the company offers an array of..

Baxter International Inc. (BAX) Stock Analysis: Navigating the Healthcare Giant’s 23.50% Potential Upside

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, offers a broad spectrum of medical instruments and supplies, catering to diverse markets ranging from hospitals to home healthcare...

Viatris Inc. (VTRS) Investor Outlook: Navigating a 12.15% Potential Upside Amidst Healthcare Challenges

Viatris Inc. (NASDAQ: VTRS), a formidable player in the healthcare sector, operates across a vast array of global markets, delivering a diverse portfolio of prescription brand drugs, generic drugs, and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds